Home > Insider Trading > Filing (0001179110-22-001692)

Filing Details

Accession Number:: 0001179110-22-001692
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-28 16:12:02
Reporting Period:: 2022-02-24

Accepted Time:: 2022-02-28 16:12:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1350653	Alphatec Holdings Inc.	ATEC	Surgical & Medical Instruments & Apparatus (3841)	202463898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1831608	Scott Lish	C/O Alphatec Spine, Inc. 1950 Camino Vida Roble Carlsbad CA 92008	Svp, Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-24	37,500	$0.00	297,850	No	4	A	Direct
Common Stock	Acquisiton	2022-02-24	51,092	$0.00	348,942	No	4	A	Direct
Common Stock	Disposition	2022-02-24	12,500	$9.44	336,442	No	4	S	Direct
Common Stock	Disposition	2022-02-25	8,000	$10.26	328,442	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On February 24, 2022, the issuer awarded 37,500 restricted stock units (RSUs) to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. The RSUs vest in three equal installments on each of February 24, 2022, February 18, 2023 and February 18, 2024.
On February 24, 2022, the issuer granted to the reporting person 51,092 RSUs. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.
Each RSU represents a contingent right to receive one share of the issuer's common stock.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.07 to $9.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.18 to $10.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.